---
$id: https://graph.org.ai/products/commodity/51162637
$type: Product
source: UNSPSC
code: "51162637"
title: "Morclofone"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Morclofone

**UNSPSC Code**: 51162637
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antitussive agent with the molecular formula C21H24ClNO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) VY62TIB872, chemically known as 4-chloro-3,5-dimethoxy-4-(2-morpholinoethoxy)benzophenone but more generally known as morclofone, which bears US NIH Compound Identifier 35949. European Medicines Agency schedules Morclofone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09065MIG. The term MORCLOFONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules morclofone in its Anatomical Therapeutic Chemical (ATC) Classification. MORCLOFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule morclofone under HS 29349990 and SITC 51579. As of Q4 2014, MORCLOFONE remains US FDA's Preferred Term for this commodity. Morclofone bears US NLM identifiers UMLS ID C0066796 and NCI Concept Code C66194. SMILES: CLC1CCC(C(=O)C2CC(OC)C(OCCN3CCOCC3)C(OC)C2)CC1.

